Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-05-15 @ 4:03 PM
Study NCT ID:
NCT00022451
Status:
COMPLETED
Last Update Posted:
2012-03-15
First Post:
2001-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tipifarnib in Treating Young Patients With Refractory Leukemia
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
010196
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None